Open AccessThe position statement of the Working Group of the Polish Psychiatric Association on the use of D2/D3 dopamine receptor partial agonists in the treatment of mental disorders
Author(s) -
Adam Wichniak,
Jerzy Samochowiec,
Agata Szulc,
Dominika Dudek,
Janusz Heitzman,
Małgorzata Janas–Kozik,
Tomasz Wolañczyk,
Joanna Rymaszewska,
Marcin Siwek,
Przemysław Bieńkowski
Publication year - 2021
Publication title -
psychiatria polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.414
H-Index - 22
eISSN - 2391-5854
pISSN - 0033-2674
DOI - 10.12740/pp/138177
Subject(s) - aripiprazole , partial agonist , extrapyramidal symptoms , antipsychotic , dopamine receptor d2 , dopamine receptor d3 , schizophrenia (object oriented programming) , psychology , medicine , akathisia , psychiatry , pharmacology , dopamine , agonist , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom